• Conley Jones, Senior Associate at Alexandria Venture Investments, Guests on BioTalk

    Conley Jones, Senior Associate at Alexandria Venture Investments, Guests on BioTalk

  • John Mumm, CEO of Deka BioSciences, joins Rich Bendis on BioTalk

    John Mumm, CEO of Deka BioSciences, joins Rich Bendis on BioTalk

  • Troy A LeMaile-Stovall, Chief Executive Officer and Executive Director of TEDCO Guests on BioTalk

    Troy A LeMaile-Stovall, Chief Executive Officer and Executive Director of TEDCO Guests on BioTalk

  • Brett Malone, Ph.D., President and CEO of the Virginia Tech Corporate Research Center, Guests on BioTalk

    Brett Malone, Ph.D., President and CEO of the Virginia Tech Corporate Research Center, Guests on BioTalk

  • New “Virginia Bio-Connect” Statewide Consortium and Scale-Up Initiative Featured on BioTalk

    New “Virginia Bio-Connect” Statewide Consortium and Scale-Up Initiative Featured on BioTalk

  • United States Pharmacopeia CEO Ronald T. Piervincenzi, Ph.D. Joins Rich Bendis on the BioTalk Podcast

    United States Pharmacopeia CEO Ronald T. Piervincenzi, Ph.D. Joins Rich Bendis on the BioTalk Podcast

  • Chris Mathia, Chief Executive Officer, Innara Health, and Keith Molzer, Managing Partner, Flyover Capital, join Rich Bendis from Kansas City on BioTalk

    Chris Mathia, Chief Executive Officer, Innara Health, and Keith Molzer, Managing Partner, Flyover Capital, join Rich Bendis from Kansas City on BioTalk

  • Dr. James Crowe, Director, Vanderbilt Vaccine Center, Guests on BioTalk

    Dr. James Crowe, Director, Vanderbilt Vaccine Center, Guests on BioTalk